Individualized Tumor Neoantigen Peptide Vaccine(The University Of Hong Kong-Shenzhen Hospital)

N/A

Report date: 2025/03/26 20:01:25

Base Information

Drug NameIndividualized Tumor Neoantigen Peptide Vaccine(The University Of Hong Kong-Shenzhen Hospital)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLung NeoplasmsColorectal NeoplasmsBreast Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesThe University Of Hong Kong-Shenzhen Hospital
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Hong Kong-Shenzhen Hospital
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsColorectal NeoplasmsBreast Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A